Please find the session links next to their corresponding agenda item.
Overview of Drug Law and Regulation
Jur Strobos, Partner, Potomac Law Group
The New Drug Approval Process: Basic Concepts
Jennifer A. Davidson, Partner, Kleinfeld, Kaplan & Becker, LLP
Wednesday, November 9
11:00 AM
11:05 AM–12:15 PM
The New Drug Approval Process: New Drug Research and Development
Marc Wagner, Associate, BakerHostetler
Enter this session: https://fdli.zoom.us/j/89525686128
12:15–12:30 PM
Break
12:30–1:50 PM
The New Drug Approval Process: NDA Submission and Review
Lauren Farruggia, Associate, Goodwin Procter LLP
Enter this session: https://fdli.zoom.us/j/86273959855
1:50–2:05 PM
Break
2:05–3:25 PM
The Abbreviated NDA (ANDA), 505(b)(2) Applications, and Patent and Exclusivity Issues
Rebecca L. Dandeker, Partner, Morgan, Lewis & Bockius LLP
Enter this session: https://fdli.zoom.us/j/86103240234
3:25–3:40 PM
Break
3:40–5:00 PM
Post-Approval Issues
Lee Rosebush, Partner, BakerHostetler
Enter this session: https://fdli.zoom.us/j/88324673543